PortfoliosLab logo
UTHR vs. COST
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between UTHR and COST is 0.37, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

UTHR vs. COST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in United Therapeutics Corporation (UTHR) and Costco Wholesale Corporation (COST). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

UTHR:

0.57

COST:

1.29

Sortino Ratio

UTHR:

0.94

COST:

1.81

Omega Ratio

UTHR:

1.14

COST:

1.24

Calmar Ratio

UTHR:

0.58

COST:

1.65

Martin Ratio

UTHR:

1.26

COST:

4.74

Ulcer Index

UTHR:

14.62%

COST:

6.04%

Daily Std Dev

UTHR:

31.71%

COST:

22.13%

Max Drawdown

UTHR:

-93.18%

COST:

-53.39%

Current Drawdown

UTHR:

-22.23%

COST:

-3.28%

Fundamentals

Market Cap

UTHR:

$14.47B

COST:

$449.51B

EPS

UTHR:

$24.93

COST:

$17.05

PE Ratio

UTHR:

12.79

COST:

59.16

PEG Ratio

UTHR:

1.43

COST:

5.36

PS Ratio

UTHR:

4.83

COST:

1.70

PB Ratio

UTHR:

2.12

COST:

17.57

Total Revenue (TTM)

UTHR:

$2.99B

COST:

$264.09B

Gross Profit (TTM)

UTHR:

$2.66B

COST:

$35.11B

EBITDA (TTM)

UTHR:

$1.56B

COST:

$11.25B

Returns By Period

In the year-to-date period, UTHR achieves a -9.63% return, which is significantly lower than COST's 13.80% return. Over the past 10 years, UTHR has underperformed COST with an annualized return of 5.77%, while COST has yielded a comparatively higher 24.24% annualized return.


UTHR

YTD

-9.63%

1M

5.20%

6M

-13.94%

1Y

17.90%

3Y*

11.45%

5Y*

22.01%

10Y*

5.77%

COST

YTD

13.80%

1M

4.73%

6M

7.29%

1Y

28.24%

3Y*

32.50%

5Y*

29.64%

10Y*

24.24%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


United Therapeutics Corporation

Costco Wholesale Corporation

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

UTHR vs. COST — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

UTHR
The Risk-Adjusted Performance Rank of UTHR is 6868
Overall Rank
The Sharpe Ratio Rank of UTHR is 7171
Sharpe Ratio Rank
The Sortino Ratio Rank of UTHR is 6363
Sortino Ratio Rank
The Omega Ratio Rank of UTHR is 6666
Omega Ratio Rank
The Calmar Ratio Rank of UTHR is 7474
Calmar Ratio Rank
The Martin Ratio Rank of UTHR is 6666
Martin Ratio Rank

COST
The Risk-Adjusted Performance Rank of COST is 8585
Overall Rank
The Sharpe Ratio Rank of COST is 8787
Sharpe Ratio Rank
The Sortino Ratio Rank of COST is 8282
Sortino Ratio Rank
The Omega Ratio Rank of COST is 8181
Omega Ratio Rank
The Calmar Ratio Rank of COST is 9090
Calmar Ratio Rank
The Martin Ratio Rank of COST is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

UTHR vs. COST - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for United Therapeutics Corporation (UTHR) and Costco Wholesale Corporation (COST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current UTHR Sharpe Ratio is 0.57, which is lower than the COST Sharpe Ratio of 1.29. The chart below compares the historical Sharpe Ratios of UTHR and COST, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

UTHR vs. COST - Dividend Comparison

UTHR has not paid dividends to shareholders, while COST's dividend yield for the trailing twelve months is around 0.46%.


TTM20242023202220212020201920182017201620152014
UTHR
United Therapeutics Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
COST
Costco Wholesale Corporation
0.46%0.49%2.87%0.76%0.54%3.38%0.86%1.08%4.81%1.09%4.06%0.97%

Drawdowns

UTHR vs. COST - Drawdown Comparison

The maximum UTHR drawdown since its inception was -93.18%, which is greater than COST's maximum drawdown of -53.39%. Use the drawdown chart below to compare losses from any high point for UTHR and COST.


Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

UTHR vs. COST - Volatility Comparison

United Therapeutics Corporation (UTHR) has a higher volatility of 8.09% compared to Costco Wholesale Corporation (COST) at 5.12%. This indicates that UTHR's price experiences larger fluctuations and is considered to be riskier than COST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading data...

Financials

UTHR vs. COST - Financials Comparison

This section allows you to compare key financial metrics between United Therapeutics Corporation and Costco Wholesale Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B20212022202320242025
794.40M
63.72B
(UTHR) Total Revenue
(COST) Total Revenue
Values in USD except per share items

UTHR vs. COST - Profitability Comparison

The chart below illustrates the profitability comparison between United Therapeutics Corporation and Costco Wholesale Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20212022202320242025
88.4%
15.1%
(UTHR) Gross Margin
(COST) Gross Margin
UTHR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, United Therapeutics Corporation reported a gross profit of 701.90M and revenue of 794.40M. Therefore, the gross margin over that period was 88.4%.

COST - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported a gross profit of 9.61B and revenue of 63.72B. Therefore, the gross margin over that period was 15.1%.

UTHR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, United Therapeutics Corporation reported an operating income of 382.80M and revenue of 794.40M, resulting in an operating margin of 48.2%.

COST - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported an operating income of 2.32B and revenue of 63.72B, resulting in an operating margin of 3.6%.

UTHR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, United Therapeutics Corporation reported a net income of 322.20M and revenue of 794.40M, resulting in a net margin of 40.6%.

COST - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Costco Wholesale Corporation reported a net income of 1.79B and revenue of 63.72B, resulting in a net margin of 2.8%.